Contract notice Delivery of Medicines with Active Ingredient OkrelizubAntineoplastic and immunomodulating agentsShort Description The subject of the public contract is to ensure the ongoing supply of medicinal products with the Okrelizumab active substance including their direct slaughter in pharmacies in individual regional health A S Deadline for Submission 20210723 10 00Type of Buyer OtherType of Contract SuppliesType of Procedure Open procedureRegulation European Union with participation by GPA countriesType of Bid Submission for all lotsAward Criteria Lowest price Disclaimer The above text is machine translated For accurate information kindly refer the original document
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.